Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.30
Delayed Data
As of 3:52pm ET
 -0.20 / -5.71%
Today’s Change
2.10
Today|||52-Week Range
4.45
+53.49%
Year-to-Date
No recent news for aTyr Pharma Inc.

Today’s Trading

Previous close3.50
Today’s open3.50
Day’s range3.25 - 3.50
Volume34,014
Average volume (3 months)195,605
Market cap$83.1M
Dividend yield--
Data as of 3:52pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+19.47%
Earnings growth (this year)+20.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.01-0.86%
MNKDMannKind Corp+0.00+0.39%
RGLSRegulus Therapeutics...-0.03-1.56%
ATNMActinium Pharmaceuti...-0.02-1.64%
Data as of 3:53pm ET, 04/28/2017

Financials

Next reporting dateJune 22, 2017
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$57.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John D. Mendlein
Vice President-
Finance
John T. Blake
Corporate headquarters
San Diego, California

Forecasts